Tehran University of Medical Sciences
Office of Vice-Chancellor for Global Strategies & International Affairs
International Human Capacity Development (IHCD)
Code : 9345-351863      Publish Date : Tuesday, October 4, 2016 Visit : 1382

Intl. Congress form | International Congress Report | International Congress Report For Faculty | 31th congress of European Association of Cardiothoracic Anesthesiology 2016

31th congress of European Association of Cardiothoracic Anesthesiology 2016
The report of 31th congress of European Association of Cardiothoracic Anesthesiology 2016 by Dr. Mahdi Najafi
Application Code :
306-0116-0063
 
Created Date : Tuesday, May 24, 2016 08:39:15Update Date : Monday, May 30, 2016 09:50:20
IP Address : 194.225.207.33Submit Date : Monday, May 30, 2016 09:52:04Email : najafik@sina.tums.ac.ir
Personal Information
Name : Mahdi
Surname : Najafi
School/Research center : School of Medicine
If you choose other, please name your Research center :  
Position : Associate professor
Tel : +98-21-88029674
Information of Congress
Title of the Congress : 31th congress of European Association of Cardiothoracic Anesthesiology 2016
Title of your Abstract : 1. Outcomes and long-term survival of patients undergoing coronary artery bypass graft surgery; the controversial role of opium as a risk marker
2. Is type D personality as important as classic risk factor for coronary artery disease?
Destination Country : Switzerland
From : Wednesday, May 11, 2016
To : Friday, May 13, 2016
Abstract(Please copy/paste the abstract send to the congress) : Introduction. Coronary artery disease includes high percentage
of cardiac surgical patients and defining outcome predictors is
essential for risk estimation and provision of services 1. Since
there are controversial and limited knowledge for the role of
opium, we aimed to evaluate long-term survival and the impact
of chronic opium consumption in isolated Coronary Artery
Bypass Graft patients.
Methods. Cohort of 566 isolated Coronary Artery Bypass Graft
patients as THC-COM, was conducted. Long-term 6.5-year
overall and opium-stratified survival, adjusted survival curves
based on opium consumption as well as possible predictors of
all-cause mortality using multiple cox regression were
evaluated.
Results. 6.5-year overall survival was 91.8%; 86.6% in opium
consumers and 92.7% in non-opium consumers (P¼0.035).
Multiple predictors of all-cause mortality included age, opium,
body mass index, ejection fraction, diabetes mellitus and
cerebral vascular disease. Patients with positive history of
opium consumption significantly tended to have lower ejection
fraction, higher creatinine level and higher prevalence of
myocardial infarction. After adjustments for confounding
variables, we found a hazard ratio of 2.16 for the risk of
mortality in opium addicted patients with a borderline p value
(P¼0.06).
Discussion. Despite the simultaneous impact of smoking as a
confounding variable and also the cardio-protective role of
opium in ischemic phase suggested in some studies, opium
might not seem unreasonable to be considered as a contributing
factor in worse long-term survival of Coronary Artery Bypass
Graft patients in addition to advanced age, low ejection fraction,
diabetes mellitus and cerebral vascular disease.
REFERENCE
1. Yoo JS, Kim JB, Jung SH, Choo SJ, Chung CH, Lee JW:
Coronary artery bypass grafting in patients with left ventricular
dysfunction: predictors of long-term survival and impact of
surgical strategies. Int J Cardiol 168(6):5316-5312, 2013.
Keywords of your Abstract : Coronary artery bypass, Outcome, Opium, Survival
Acceptance Letter : http://gsia.tums.ac.ir/images/UserFiles/30442/Forms/306/Acceptance letter EACTA 2016_1.pdf
The presentation : Oral
The Cover of Abstract book : http://gsia.tums.ac.ir/images/UserFiles/30442/Forms/306/Cover_1.pdf
Published abstract in the abstract book with the related code : http://gsia.tums.ac.ir/images/UserFiles/30442/Forms/306/6_5_year_survival_Opium.pdf
Where has your abstract been indexed? : ISI
If you choose other, please name :  
The Congress Reporting Form
How many volunteers were present at the Congress? : 600
Delegates from which countries presented in the congress? : 40 countries (Australia, USA, Japan, Peru, middle east, Nepal, almost all European countries)
Were the delegates of any other organizations present in the congress? : Yes
If yes, please write the names of the organizations in the box : EACTS, SCA, ...
What were the responses to your talking points? Were specific questions or concerns raised? : Overall was clear and interesting to them. Moreover they got surprised with our settings and statistics. The president of SCA (EACTA counterpart in USA) was chair of my session and I think my presentation and explanations about our center and TUMS changed her mind about Iran.
If you met staff members, please list their full names & positions. : Manfred Seeberger Congress chair
Peter Rosseel EACTA president
Bodil Rassmussen President elect
Fabio Guraccino Chair scientific committee- EACTA
Marco Ranucci Past president-EACTA
Linda Shore president SCA
many other colleagues...
Please inform us if there are any follow up actions we need to talk with the members of the congress : We talked about further cooperation in three fields:
Research, Education, patient management.
I need your experiences and support to finalize these negotiations. We tried to make ties between Iranian Society of Cardiac Anesthesia (ISCA) and EACTA and?or SCA. I'm member of directory board of ISCA. The other line was mutual relations between Tehran Heart Center and/or TUMS in one side and counterpart hospitals? universities on the other part. We started this from 4th joint cardiovascular congress in March 2016 in Tehran where we hosted many guests from other countries including EACTA president Prof Rosseel.
Your experiences about the travel processes(Providing ticket, accommodation,...) : Everywhere in the world has expected and unexpected experiences.
Switzerland is really wealthy country with fantastic natural scenes. We met many kind people and some bad sports too.
Please give a briefing of your own observations and outcomes of the congress: : The congress was a big and concise review of last updates on cardiac anesthesia as well as a good opportunity to get involved with research projects and networking with colleagues.
Among topics I was interested in those contains answers to my daily practice problems or difficult cases. I was interested in reports of clinical trials related to my field of research too. One of them was on corticosteroids. Our center was a big branch of an international trial named "SIRS". There was similar multicenter study in Germany. Database manager of German study Stefan Dieleman had a good presentation comparing these two studies. They were preparing a proposal to repeat this study in a group of younger patients. I declared that we are ready to collaborate in their next trial.
I tried to be active participant in as many sessions as possible. We have had many patients and our experiences are useful for other colleagues. I commented on anesthesia for cardiac operation during pregnancy, side effects of using newer cardiopledgic solutions, magnesium administration during cardiac operations